Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Pat-409
2. Bld-0409
3. 6b7tyb2mjx
4. 1782070-21-6
5. 3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluorobenzoic Acid
6. Benzoic Acid, 3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluoro-
7. Unii-6b7tyb2mjx
8. Cudetaxestat [inn]
9. Chembl4802146
10. Schembl16739453
11. Bdbm555280
12. Ex-a6053
13. Cudetaxestat (synonyms: Bld-0409)
14. Us11344533, Compound 1-13
15. Hy-145561
16. Cs-0376048
17. Synthesis Of 3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluorobenzoic Acid
| Molecular Weight | 482.3 g/mol |
|---|---|
| Molecular Formula | C21H15Cl2F2N3O2S |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 481.0230096 g/mol |
| Monoisotopic Mass | 481.0230096 g/mol |
| Topological Polar Surface Area | 85.4 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 654 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cudetaxestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cudetaxestat, including repackagers and relabelers. The FDA regulates Cudetaxestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cudetaxestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cudetaxestat supplier is an individual or a company that provides Cudetaxestat active pharmaceutical ingredient (API) or Cudetaxestat finished formulations upon request. The Cudetaxestat suppliers may include Cudetaxestat API manufacturers, exporters, distributors and traders.
Cudetaxestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cudetaxestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cudetaxestat GMP manufacturer or Cudetaxestat GMP API supplier for your needs.
A Cudetaxestat CoA (Certificate of Analysis) is a formal document that attests to Cudetaxestat's compliance with Cudetaxestat specifications and serves as a tool for batch-level quality control.
Cudetaxestat CoA mostly includes findings from lab analyses of a specific batch. For each Cudetaxestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cudetaxestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Cudetaxestat EP), Cudetaxestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cudetaxestat USP).
LOOKING FOR A SUPPLIER?
